1st Quarter - Report

AVENUE SOLUTIONS for MERCK & CO. INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

CHIP reauthorization and Medicare extenders; PABA reauthorization; Antibiotics/stewardship; Value of prescription drugs; Issues related to healthcare discussions/offsets for budget deal and healthcare extender policies; H.R. 1892 / PL 115-123, Bipartisan Budget Act of 2018; H.R. 1625 / PL 115-141, Omnibus/Consolidated Appropriations Act of 2018

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1892 (115th), H.R. 1625 (115th)

Medicare/Medicaid MMM

Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; Value of prescription drugs

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.